A detailed history of Crewe Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Crewe Advisors LLC holds 290 shares of EW stock, worth $19,650. This represents 0.0% of its overall portfolio holdings.

Number of Shares
290
Previous 290 -0.0%
Holding current value
$19,650
Previous $26,000 26.92%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $21,036 - $27,712
290 New
290 $27,000
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $8,985 - $10,225
-121 Reduced 52.84%
108 $8,000
Q4 2022

Feb 07, 2023

SELL
$68.3 - $87.44 $9,835 - $12,591
-144 Reduced 38.61%
229 $17,000
Q3 2022

Nov 14, 2022

BUY
$82.37 - $107.29 $6,260 - $8,154
76 Added 25.59%
373 $31,000
Q2 2022

Aug 02, 2022

BUY
$86.5 - $128.27 $25,690 - $38,096
297 New
297 $28,000
Q4 2021

Feb 10, 2022

SELL
$106.37 - $130.68 $3,191 - $3,920
-30 Closed
0 $0
Q3 2020

Oct 13, 2020

BUY
$67.19 - $87.44 $2,015 - $2,623
30 New
30 $2,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Crewe Advisors LLC Portfolio

Follow Crewe Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crewe Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crewe Advisors LLC with notifications on news.